Showing 7621 - 7630 of 8826 results
Caring for the Ages
April 6, 2026
Suzetrigine (brand name Journavx) is a recently approved, first-in-class, oral, non-opioid analgesic indicated for the treatment of moderate to severe acute pain in adults. Approved by the U.S. Food and Drug Administration (FDA) in 2025, it represents the first novel mechanistic class of oral analgesic in ...
Landing Page
Candidate - Vice President
Caring for the Ages
February 26, 2016
Caring for the Ages
December 28, 2020
Caring for the Ages
September 30, 2021
JAMDA
October 22, 2020
Support care is rarely assessed and offered to people with long-term neurologic conditions, particularly Parkinson's disease. This study aimed to assess the symptom burden and unmet support care needs in people with mild to severe Parkinson's disease.
JAMDA
March 26, 2019
Neuropsychiatric symptoms (NPS) have been recognized to increase the risk of dementia among individuals with mild cognitive impairment (MCI). However, it is unclear whether the risk is shared across the various NPS or driven primarily by selected few symptoms. This study sought to provide confirmatory evid...
JAMDA
May 1, 2024
To investigate longitudinal changes in symptomatic and preventive medication use among community-dwelling people with and without Alzheimer's disease (AD) 5 years pre- and post-AD diagnosis.
Practice Management Tools
Synopsis of Federal Regulations in the Nursing Facility: Implications for Attending Physicians and Medical Directors is an indispensable resource tool for medical directors, attending physicians, and other post-acute and long-term care practitioners. The Synopsis of Federal Regulations contains summary cha...
Caring for the Ages
April 29, 2025